Public Profile

Kelun Group

Kelun Group, officially known as Kelun Pharmaceutical Co., Ltd., is a prominent player in the pharmaceutical industry, headquartered in China (CN). Founded in 2004, the company has rapidly expanded its operations across major regions, including Asia, Europe, and North America, establishing a strong global presence. Specialising in the research, development, and manufacturing of high-quality generic and innovative drugs, Kelun Group is recognised for its commitment to advanced biopharmaceuticals and injectable products. The company’s unique approach to drug formulation and production has positioned it as a leader in the market, with notable achievements in regulatory compliance and product quality. With a focus on enhancing healthcare solutions, Kelun Group continues to make significant strides in the pharmaceutical sector, contributing to improved patient outcomes worldwide.

DitchCarbon Score

How does Kelun Group's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

22

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Kelun Group's score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

17%

Let us know if this data was useful to you

Kelun Group's reported carbon emissions

In 2024, Kelun Group reported total carbon emissions of approximately 2,845,549,250 kg CO2e. This figure includes about 2,361,763,170 kg CO2e from Scope 1 emissions and approximately 483,786,080 kg CO2e from Scope 2 emissions. In the previous year, 2023, the company recorded total emissions of about 2,659,459,920 kg CO2e, with Scope 1 emissions at approximately 2,190,590,170 kg CO2e and Scope 2 emissions around 468,869,750 kg CO2e. Despite these substantial figures, Kelun Group has not disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of Scope 3 emissions data indicates a potential area for improvement in their climate strategy. Overall, while Kelun Group's emissions remain significant, their commitment to addressing climate change through measurable targets is currently unclear.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20232024
Scope 1
2,190,590,170
0,000,000,000
Scope 2
468,869,750
000,000,000
Scope 3
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Kelun Group's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Kelun Group is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Kelun Group is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd.

CN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Baiyunshan

CN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Baxter

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

CHINA NATIONAL PHARMACEUTICAL GROUP

CN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Bayer

DE
Chemicals nec
Updated 1 day ago

Huadong Medicine Co., Ltd

CN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers